Mutations in the quinolone resistance-determining regions of gyrA and parC in enterobacteriaceae isolates from Brazil

Brazilian Journal of Microbiology

Volumn 43, Issue 4, 2012, Pages 1309-1314

  Minarini, Luciene A R ^a,b   Darini, Ana Lucia C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Enterobacteriaceae; gyrA; Mutations; parC; Quinolone resistance determining region

Indexed keywords

EID: 84874377221     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822012000400010     Document Type: Article

References (27)

1. Biedenbach, D.J.; Toleman, M.; Walsh, T.R.; Jones, R.N. (2006). Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn. Microbiol. Infect. Dis. 54 (1), 13-21.
2. Chenia, H.Y.; Pillay, B.; Pillay, D. (2006). Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens. J. Antimicrob. Chemother. 58 (6), 1274-1278.
3. CLSI (2011). Performance standards for antimicrobial susceptibility testing; Twenty-first informational supplement Document M100-S21. Wayne, Pa: Clinical and Laboratory Standards Institute.
4. Deguchi, T.; Yasuda, M.; Nakano, M.; Ozeki, S.; Kanematsu, E.; Nishino, Y.; Ishihara, S.; Kawada, Y. (1997). Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae. J. Antimicrob. Chemother. 40 (4), 543-549.
5. Gales, A.C.; Gordon, K.A.; Wilke, W.W.; Pfaller, M.A.; Jones, R.N. (2000). Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America. Diagn. Microbiol. Infect. Dis. 36 (1), 61-64.
6. Hansen, L.H.; Jensen, L.B.; Sørensen H.I.; Sørensen S.J. (2007). Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. J. Antimicrob. Chemother. 60(1), 145-147.
7. Hooper, D.C. (2002). Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect. Dis. 2 (9), 530-538.
8. Hurst, M.; Lamb, H.M.; Scott, L.J.; Figgitt, D.P. (2002). Levofloxacin: an updated review of its use in the treatment of bacterial infections. Drugs 62 (14), 2127-2167.
9. Jacoby, T.S.; Kuchenbecker, R.S.; Dos Santos, R.P.; Magedanz, L.; Guzatto, P.; Moreira, L.B. (2010). Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit. J. Hosp. Infect. 75 (1), 23-27.
10. Mammeri, H.; Van De Loo, M.; Poirel, L.; Martinez-Martinez, L.; Nordmann, P. (2005). Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob. Agents Chemother. 49 (1), 71-76.
11. Martinez-Martinez, L.; Pascual, A.; Jacoby, G.A. (1998). Quinolone resistance from a transferable plasmid. Lancet 351 (9105), 797-799.
12. Minarini, L.A.; Gales, A.C.; Darini, A.L. (2007). First report of plasmid-mediated resistance to quinolones and cefotaxime in an Enterobacter cloacae isolated from an outpatient in Brazil. Antimicrob. Agents Chemother. 51 (1), 401-402.
13. Minarini, L.A.; Gales, A.C.; Palazzo, I.C.; Darini, A.L. (2007). Prevalence of community-occurring extended spectrum beta-lactamase-producing Enterobacteriaceae in Brazil. Curr. Microbiol. 54 (5), 335-341.
14. Moon, D.C.; Seol, S.Y.; Gurung, M.; Jin, J.S.; Choi, C.H.; Kim, J.; Lee, Y.C.; Cho, D.T.; Lee, J.C. (2010). Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolone in Escherichia coli isolates. Int. J. Antimicrob. Agents 35 (1), 76-79.
15. Naheed, A.; Kalluri, P.; Talukder, K.A.; Faruque, A.S.; Khatun, F.; Nair, G.B.; Mintz, E.D.; Breiman, R.F. (2004). Fluoroquinolone-resistant Shigella dysenteriae type 1 in northeastern Bangladesh. Lancet Infect. Dis. 4 (10), 607-608.
16. Nordmann, P.; Poirel, L. (2005). Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J. Antimicrob. Chemother. 56 (3), 463-469.
17. Ogbolu, D.O.; Daini, O.A.; Ogunledun, A.; Alli, A.O.; Webber, M.A. (2010). High levels of multidrug resistance in clinical isolates of Gram-negative pathogens from Nigeria. Int. J. Antimicrob. Agents 37 (1), 62-66.
18. Pereira, A.S.; Andrade, S.S.; Monteiro, J.; Sader, H.; Pignatari, A.C.C.; Gales, A.C. (2007). Evaluation of the susceptibility profiles, genetic similarity and presence of qnr gene in Escherichia coli resistant to ciprofloxacin isolated in Brazilian hospitals. Braz. J. Infect. Dis. 11 (1), 40-43.
19. Poole, K. (2005). Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56 (1), 20-51.
20. Robicsek, A.; Sahm, D.F.; Strahilevitz, J.; Jacoby, G.A.; Hooper, D.C. (2005). Broader distribution of plasmid-mediated quinolone resistance in the United States. Antimicrob. Agents Chemother. 49 (7), 3001-3003.
21. Ruiz, J. (2003). Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother. 51 (5), 1109-1117.
22. Tumbarello, M.; Trecarichi, E.M.; Bassetti, M.; De Rosa, F.G.; Spanu, T.; Di Meco, E.; Losito, A.R.; Parisini, A.; Pagani, N.; Cauda, R. (2011). Identifying patients harboring ESBL-Producing Enterobacteriaceae on hospital admission: Derivation and validation of a scoring system. Antimicrob. Agents Chemother. (May 2).
23. Vernaz, N.; Huttner, B.; Muscionico, D.; Salomon, J.L.; Bonnabry, P.; López-Lozano, J.M.; Beyaert, A.; Schrenzel, J.; Harbarth, S. (2011). Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. J. Antimicrob. Chemother. 66 (4), 928-935.
24. Vila, J.; Ruiz, J.; Marco, F.; Barcelo, A.; Goñi, P.; Giralt, E.; Jimenez de Anta, T. (1994). Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob. Agents Chemother. 38 (10), 2477-2479.
25. Vila, J.; Ruiz, J.; Navia, M.M. (1999). Molecular bases of quinolone resistance acquisition in Gram-negative bacteria. In: S.G. Pandaly, editor. Recent Res Devel Antimicrob Agents Chemother. India: Reseach Signpost; p. 323-344.
26. Weigel, L.M.; Steward, C.D.; Tenover, F.C. (1998). gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob. Agents Chemother. 42 (10), 2661-2667.
27. Yamane, K.; Wachino, J.; Suzuki, S.; Kimura, K.; Shibata, N.; Kato, H.; Shibayama, K.; Konda, T.; Arakawa, Y. (2007). New Plasmid-Mediated Fluoroquinolone Efflux Pump, QepA, Found in an Escherichia coli Clinical Isolate. Antimicrob. Agents Chemother. 51 (9), 3354-3360.